Signal transduction inhibitors as radiosensitizers. (Record no. 12471390)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01268 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514063637.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200306s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1568-0118 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.2174/1568011023353651 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tenzer, A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20030610 |
245 00 - TITLE STATEMENT | |
Title | Signal transduction inhibitors as radiosensitizers. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Current medicinal chemistry. Anti-cancer agents |
Date of publication, distribution, etc. | Nov 2002 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 727-42 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme Inhibitors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ligands |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiation-Sensitizing Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiotherapy |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zingg, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Riesterer, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vuong, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bodis, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pruschy, M |
773 0# - HOST ITEM ENTRY | |
Title | Current medicinal chemistry. Anti-cancer agents |
Related parts | vol. 2 |
-- | no. 6 |
-- | p. 727-42 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.2174/1568011023353651">https://doi.org/10.2174/1568011023353651</a> |
Public note | Available from publisher's website |
No items available.